Daishin Securities Seeks Billions in Claims from Employees Over Lime Fund Scandal

COMPANY / Reporter Paul Lee / 2025-04-09 04:06:12

Photo = Daishin Securities

 

 

[Alpha Biz= Paul Lee] Daishin Securities has sparked controversy by seeking billions of Korean won in claims from employees who sold the Lime Funds, which caused a financial loss of 1.6 trillion Korean won. While the labor union criticizes the company for shifting responsibility onto employees, the company insists that customer damages were caused by some employees' incomplete sales practices.



On the 8th, the Daishin Securities branch of the National Office and Financial Services Labor Union held a press conference in front of Daishin Securities' headquarters in Jung-gu, Seoul, condemning the claim for restitution from the employees involved in selling the Lime Funds.



Twelve employees, who previously worked at the Banpo WM Center, were recently charged by SGI Seoul Guarantee Insurance for a claim of 1.8 billion Korean won in bond insurance payments. The individual amounts vary from several million to up to 240 million Korean won per person. 

 

 

Daishin Securities had subscribed to bond insurance from Seoul Guarantee Insurance to cover the damages caused by employees. If Daishin Securities receives the insurance payment, Seoul Guarantee Insurance then seeks to recover the amount from the employees. The company clarified that the bond insurance claim by Seoul Guarantee Insurance was made based on Daishin Securities' decision.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

FADU Avoids Delisting Review Despite Prosecutorial Indictment, Trading Resumes
Advertising Industry Distances Itself from Actor Kim Seon-ho Amid Tax Evasion Allegations
LG Chem Steps Up Legal Offensive Against China’s Top Cathode Maker Ronbay
Korea Development Bank Calls for Swift Sale of HMM Stake to Ease Financial Burden
Suspicious Money Laundering Transactions Hit Record High in South Korea Amid Surge in Crypto-Linked Crime
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS